124 related articles for article (PubMed ID: 16239378)
1. Stimulation of autoimmunity by toll-like receptor ligands.
Limmer A; Ganss R; Garbi N; Arnold B; Hämmerling GJ
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv15-7. PubMed ID: 16239378
[No Abstract] [Full Text] [Related]
2. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.
Kanzler H; Barrat FJ; Hessel EM; Coffman RL
Nat Med; 2007 May; 13(5):552-9. PubMed ID: 17479101
[TBL] [Abstract][Full Text] [Related]
3. Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance.
Ehlers M; Ravetch JV
Trends Immunol; 2007 Feb; 28(2):74-9. PubMed ID: 17197239
[TBL] [Abstract][Full Text] [Related]
4. Immune system's Toll-like receptors have good opportunity for cancer treatment.
Schmidt C
J Natl Cancer Inst; 2006 May; 98(9):574-5. PubMed ID: 16670380
[No Abstract] [Full Text] [Related]
5. Nucleic acid recognizing Toll-like receptors and autoimmunity.
von Landenberg P; Bauer S
Curr Opin Immunol; 2007 Dec; 19(6):606-10. PubMed ID: 18060756
[TBL] [Abstract][Full Text] [Related]
6. Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway.
Chen R; Alvero AB; Silasi DA; Mor G
Am J Reprod Immunol; 2007 Feb; 57(2):93-107. PubMed ID: 17217363
[TBL] [Abstract][Full Text] [Related]
7. Endogenous TLR ligands and autoimmunity.
Wagner H
Adv Immunol; 2006; 91():159-73. PubMed ID: 16938540
[TBL] [Abstract][Full Text] [Related]
8. BAFF synthesis by rheumatoid synoviocytes is positively controlled by alpha5beta1 integrin stimulation and is negatively regulated by tumor necrosis factor alpha and Toll-like receptor ligands.
Alsaleh G; Messer L; Semaan N; Boulanger N; Gottenberg JE; Sibilia J; Wachsmann D
Arthritis Rheum; 2007 Oct; 56(10):3202-14. PubMed ID: 17907168
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors in inflammation, infection and cancer.
Chen K; Huang J; Gong W; Iribarren P; Dunlop NM; Wang JM
Int Immunopharmacol; 2007 Oct; 7(10):1271-85. PubMed ID: 17673142
[TBL] [Abstract][Full Text] [Related]
10. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma.
Erridge C; Burdess A; Jackson AJ; Murray C; Riggio M; Lappin D; Milligan S; Spickett CM; Webb DJ
Eur J Clin Invest; 2008 Oct; 38(10):713-20. PubMed ID: 18837796
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors, inflammation and tumor in the human female reproductive tract.
Yu L; Wang L; Chen S
Am J Reprod Immunol; 2009 Jul; 62(1):1-8. PubMed ID: 19527227
[TBL] [Abstract][Full Text] [Related]
12. The role of TLR activation in inflammation.
Sabroe I; Parker LC; Dower SK; Whyte MK
J Pathol; 2008 Jan; 214(2):126-35. PubMed ID: 18161748
[TBL] [Abstract][Full Text] [Related]
13. gp96 leads the way for toll-like receptors.
Harding CV
Immunity; 2007 Feb; 26(2):141-3. PubMed ID: 17307701
[TBL] [Abstract][Full Text] [Related]
14. Multiple roles of Toll-like receptor signaling in atherosclerosis.
Björkbacka H
Curr Opin Lipidol; 2006 Oct; 17(5):527-33. PubMed ID: 16960501
[TBL] [Abstract][Full Text] [Related]
15. Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors.
Romagne F
Drug Discov Today; 2007 Jan; 12(1-2):80-7. PubMed ID: 17198976
[TBL] [Abstract][Full Text] [Related]
16. The role of innate immunity in autoimmune tissue injury.
Allam R; Anders HJ
Curr Opin Rheumatol; 2008 Sep; 20(5):538-44. PubMed ID: 18698174
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
Krieg AM; Vollmer J
Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells.
Liu G; Zhao Y
Immunology; 2007 Oct; 122(2):149-56. PubMed ID: 17848162
[TBL] [Abstract][Full Text] [Related]
19. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.
Corthals SL; Wynne K; She K; Shimizu H; Curman D; Garbutt K; Reid GS
Br J Haematol; 2006 Feb; 132(4):452-8. PubMed ID: 16412017
[TBL] [Abstract][Full Text] [Related]
20. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.
Oganesyan G; Saha SK; Guo B; He JQ; Shahangian A; Zarnegar B; Perry A; Cheng G
Nature; 2006 Jan; 439(7073):208-11. PubMed ID: 16306936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
